AI-generated summary
The authors randomly assigned 15 patients with carpal tunnel syndrome to either 860 nm laser treatment or sham laser over five weeks in a double-blind trial. Both groups showed symptom improvement, but the authors report no significant difference between the laser and sham groups on any outcome measure, concluding that the laser was no more effective than sham treatment.
- Participants
- 15
- Who or what was studied
- Patients with carpal tunnel syndrome aged 34 to 67 years
- Wavelengths
- 860 nm
- Limits stated in the abstract
- The trial was small, with only 7 to 8 patients per group, and the abstract does not describe a placebo-independent confirmation of the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 860 nm
- Energy density (fluence)
- 6 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Randomized controlled trial, Control group, Sham, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.